Abstract
Polycystic ovary syndrome (PCOS) is the most prevalent female endocrinopathy and the largest single cause of anovulatory infertility. The PCOS is characterized by multiple small antral follicles arrested in their development but nonatretic and viable. The hyperexpression of some growth factors (e.g. EGF/TGF alpha) in PCOS, considered to be survival or antiapoptotic factors, led to the hypothesis of their involvement in the blocking of apoptosis and atresia leading to an accumulation of multiple small antral follicles. Diminished FSH stimulation and accumulation of androgens could explain the arrest of progress to the preovulatory stage. Further investigation of the pathogenesis of PCOS is needed on the modulation of tumour suppressor and apoptosis genes such as p53, BAX or the APO/FAS system and the over expression of survival genes such as BCL2.
Similar content being viewed by others
References
Hughes F.M., Gorospe W.C. Biochemical indentification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia. Endocrinol. 129: 2415, 1991.
Tilly J.L. Ovarian follicular atresia: a model to study the mechanism of physiological cell death. Endocr. J. 1: 67, 1993.
Hsueh A.J.W., Billig H., Tsafriri A. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr. Rev. 15: 707, 1994.
Tilly J.L. Apoptosis and ovarian function. Rev. Reprod. 1: 162, 1996.
Amsterdam A., Selvaraj N. Control of differentiation, transformation and apoptosis in granulosa cells by oncogenes, oncoviruses and tumor suppressor genes. Endocr. Rev. 18: 435, 1997.
Gibori G., Khan I., Warshaw M.L. et al. Placental derived regulators and the complex control of luteal cell function. Recent Prog. Horm. Res. 44: 377, 1988.
Juengel J.L., Garverick H.A., Johnson A.L. et al. Apoptosis during luteal regression in cattle. Endocrinology 132: 249, 1993.
Zheng J., Fricke P.M., Reynolds L.P., Redmer D.A. Evaluation of growth, cell proliferation and cell death in bovine corpora lutea throughout the estrus cycle. Biol. Reprod. 51: 623, 1994.
Jo T., Tomiyama T., Ohashi K. et al. Apoptosis of cultured mouse luteal cells induced by tumor necrosis factor-alpha and interferon gamma. Anat. Rec. 241: 70, 1995.
Fraser H.M., Lunn S.F., Cowen G.M., Illingworth P.J. Induced luteal regression in the primate: evidence for apoptosis and changes in c-myc protein. J. Endocrinol. 147: 131, 1995.
Pitzer F., Dantes A., Fuchs T. et al. Removal of proteasomes from the nucleus and their accumulation in apoptotic blebs during programmed cell death. FEBS Lett. 394: 46, 1996.
Amsterdam A., Breckwoldt M., Dantes A. et al. Ultrastructural aspects of cAMP and p53-mediated apoptosis in normal and ras- transformed granulosa cells. In: Tilly J.L., Strauss III J.F., Tenniswood M. (Eds.), Serono Symposium on Cell Death in Reproductive Physiology. Springer, New York, 1997.
Tilley J.L., Tilly K.I., Perez G.I. The genes of cell death cellular susceptibility to apoptosis in the ovary: a hypothesis. Cell Death Diff. 4: 180, 1997.
Amersterdam A., Keren-Tal I., Aharoni D., Dantes A. Control of differentiation and programmed cell death by cAMP and p53-generated signals in ras-transformed cells. In: Waxman A. (Ed.), Challenges of Modern Medicine, Vol 10, Differentiation Therapy. Ares-Serono Publications, Rome, 1996, p. 83.
Amsterdam A., Aharoni A., Dantes A. et al. Involvement of protooncogenes, oncogenes and oncoviruses in granulosa cell steroidogenesis, carcinogenesis and programmed cell death. In: Fujimoto S., Hsueh J.F., Strauss II T., Tanaka T. (Eds.), New Achievements in Research of Ovarian Function. Ares-Serono, Rome, 1995, p. 315.
Amsterdam A., Keren-Tal I., Aharoni D. p53 and cAMP in differentiation and apoptosis in steroidogenic cells. Steroids 61: 252, 1996.
Amsterdam A., Dantes A., Selvaraj N., Aharoni D. Apoptosis in steroidogenic cells: struture-function analysis. Steroids 62: 207, 1997.
De Felici M. Ovarian follicular atresia: a model for apoptosis. Cell Death Differ. 4: 260, 1997.
Tilly K.I., Banerjee S., Banerjee P.P., Tilly J.L. Expression of the p-53 and Wilmis tumor suppressor genes in the rat ovary: gonadotropin repression in vivo and immunohistochemical localization of p53 protein to apoptotic granulosa cells of atretic follicles. Endocrinology 136: 1394, 1995.
Keren-Tal I., Suh B.S., Dantes A. et al. Involvement of p53 expression in cAMP mediated apoptosis in immortalized granulosa cells. Exp. Cell Res. 218: 283, 1995.
Tilly J.L., Tilly K.I., Kenton L.M., Johnson A.L. Expression of members of the Bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin mediated inhibition of granulosa cell apoptosis is associated with decreased Bax and constitutive Bcl-2 and Bcl-x long messenger ribonucleic acid levels. Endocrinology 136: 232, 1995.
Shaulian E., Resnitzky D., Shifman O. et al. Enhancement of cell survival by bFGF correlates with increased Mdm2 oncoprotein levels. Oncogene 15: 2717, 1997.
Aharoni D., Dantes A., Oren M., Amsterdam A. c-AMP mediated signals as determinants for apoptosis in primary granulosa cells. Exp. Cell Res. 218: 271, 1995.
Hosokawa K., Dantes A., Schere-Levy C. et al. Modulation of MDM2 expression and p53-induced apoptosis in immortalized human ovarian granulosa cells. In press.
Franks S., Gharani N., Waterworth D. et al. The genetic basis of polycystic ovary syndrome. Hum. Reprod. 12: 2641, 1997.
Adams J., Franks S., Poison D.W. et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin releasing hormone. Lancet ii: 1375, 1985.
Hughesdon P.E. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called “hyperthecosis”. Obstet. Gynecol. Survey 37: 59, 1982.
Van der Meer M., Hompes P.G.A., De Boer J. et al. Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome. Clin. Endocrinol. Metab. 83: 423, 1998.
Mason H.D., Willis D.S., Beard R.W. et al. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotrophins and sex steroids in follicular fluids. J. Clin. Endocrinol. Metab. 79: 1355, 1994.
Dong J., Albertini D.F., Nishimori K. et al. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383: 531, 1996.
Willis D., Mason H.D., Watson H. et al. Premature response to LH of granulosa cells to women with polycystic ovary syndrome. Endocrinology Suppl. 152: 241, 1997.
Almahbobi G., Nagodavithane A., Trounson A.O. Effects of epidermal growth factor, transforming growth factor alpha and androstendione on follicular growth and aromatization in culture. Hum. Reprod. 10: 2767, 1995.
Mason H.D., Margara R., Winston R.M.L. et al. Inhibition of estradiol production by epidermal growth factor in human granulosa cells of normal and polycystic ovaries. Clin. Endocrinol. 33: 511, 1990.
Bendell J.J., Dorrington J.H. Epidermal growth factor influences growth and differentiation of rat granulosa cells. Endocrinology 127: 533, 1990.
Maruo T., Ladnes-Lave C.A., Samoto T. et al. Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression. Endocrinology 132: 924, 1993.
Mason H.D., Carr L., Leake R., Franks S. Production of transforming growth factor alpha by normal and polycystic ovaries. Clin. Endocrinol. Metab. 80: 2053, 1995.
Volpe A., Coukos G., D’Ambrogio G. et al. Follicular fluid steroid and epidermal growth factor content, and in vitro estrogen release by granulosa luteal cells from patients with polycystic ovaries in an IVF/ET program. Eur. J. Obstet. Gynacol. Reprod. Biol. 42: 195, 1991.
Cataldo N.A. Insulin-like growth factor binding proteins: do they play a part in polycystic ovary syndrome? Sem. Reprod. Endocrinol. 15: 123, 1997.
Hsu S.Y., Lai R.J., Finegold M., Hsueh A.J. Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicle apoptosis, enhanced folliculogenesis and increased germ cell tumorigenesis. Endocrinology 137: 4837, 1996.
Ma Y.J., Dissen G.A., Merlino G. et al. Overexpression of a human transforming growth factor alpha (TGF-alpha) transgene reveals a dual antagonistic role of TGF-alpha in female sexual development. Endocrinology 135: 1392, 1994.
Tilly J.L., Billig H., Kowalski K.I., Hsueh A.J. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase dependent mechanism. Mol. Endocrinol. 6: 1942, 1992.
Almahbobi G., Misajon A., Hutchinson P. et al. Hyperexpression of epidermal growth factor receptors in granulosa cells from women with polycystic ovaries. Fertil. Steril. In press.
Aharoni D., Meiri I., Atzmon R. et al. Differential effect of components of the extracellular matrix on differentiation and apoptosis. Curr. Biol. 7: 43, 1997.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Homburg, R., Amsterdam, A. Polycystic ovary syndrome — loss of the apoptotic mechanism in the ovarian follicles?. J Endocrinol Invest 21, 552–557 (1998). https://doi.org/10.1007/BF03350780
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350780